Roger Royster to Double-Blind Method
This is a "connection" page, showing publications Roger Royster has written about Double-Blind Method.
Connection Strength
0.163
-
Zvara DA, Groban L, Rogers AT, Prielipp RC, Murphy B, Hines M, Hammon JW, Kon ND, Royster RL. Prophylactic nitroglycerin did not reduce myocardial ischemia during accelerated recovery management of coronary artery bypass graft surgery patients. J Cardiothorac Vasc Anesth. 2000 Oct; 14(5):571-5.
Score: 0.043
-
Zvara DA, Brooker RF, McCall WV, Foreman AS, Hewitt C, Murphy BA, Royster RL. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy. Convuls Ther. 1997 Sep; 13(3):165-74.
Score: 0.035
-
MacGregor DA, Butterworth JF, Zaloga CP, Prielipp RC, James R, Royster RL. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest. 1994 Sep; 106(3):835-41.
Score: 0.028
-
Butterworth JF, Zaloga GP, Prielipp RC, Tucker WY, Royster RL. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone. Chest. 1992 Jan; 101(1):174-80.
Score: 0.024
-
Butterworth J, Legault C, Stump DA, Coker L, Hammon JW, Troost BT, Royster RL, Prough DS. A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1999 Dec; 13(6):690-4.
Score: 0.010
-
Butterworth JF, Legault C, Royster RL, Hammon JW. Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg. 1998 Mar; 86(3):461-7.
Score: 0.009
-
Butterworth JF, Royster RL, Prielipp RC, Lawless ST, Wallenhaupt SL. Amrinone in cardiac surgical patients with left-ventricular dysfunction. A prospective, randomized placebo-controlled trial. Chest. 1993 Dec; 104(6):1660-7.
Score: 0.007
-
Johnston WE, Robertie PG, Butterworth JF, Royster RL, Kon ND. Is calcium or ephedrine superior to placebo for emergence from cardiopulmonary bypass? J Cardiothorac Vasc Anesth. 1992 Oct; 6(5):528-34.
Score: 0.006